BBC vs. LLY
Compare and contrast key facts about Virtus LifeSci Biotech Clinical Trials ETF (BBC) and Eli Lilly and Company (LLY).
BBC is a passively managed fund by Virtus Investment Partners that tracks the performance of the LifeSci Biotechnology Clinical Trials Index. It was launched on Dec 16, 2014.
Performance
BBC vs. LLY - Performance Comparison
Loading graphics...
BBC vs. LLY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 7.95% | 63.77% | -1.11% | -1.80% | -35.13% | -22.31% | 30.32% | 63.81% | -18.29% | 57.85% |
LLY Eli Lilly and Company | -14.27% | 40.25% | 33.30% | 60.91% | 34.26% | 66.08% | 31.04% | 16.14% | 40.45% | 17.83% |
Returns By Period
In the year-to-date period, BBC achieves a 7.95% return, which is significantly higher than LLY's -14.27% return. Over the past 10 years, BBC has underperformed LLY with an annualized return of 8.41%, while LLY has yielded a comparatively higher 30.92% annualized return.
BBC
- 1D
- 7.67%
- 1M
- -1.98%
- YTD
- 7.95%
- 6M
- 55.07%
- 1Y
- 141.32%
- 3Y*
- 25.09%
- 5Y*
- -3.63%
- 10Y*
- 8.41%
LLY
- 1D
- 3.74%
- 1M
- -12.57%
- YTD
- -14.27%
- 6M
- 20.93%
- 1Y
- 12.19%
- 3Y*
- 39.90%
- 5Y*
- 39.16%
- 10Y*
- 30.92%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BBC vs. LLY — Risk / Return Rank
BBC
LLY
BBC vs. LLY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Clinical Trials ETF (BBC) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BBC | LLY | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 3.52 | 0.29 | +3.23 |
Sortino ratioReturn per unit of downside risk | 3.86 | 0.69 | +3.17 |
Omega ratioGain probability vs. loss probability | 1.47 | 1.10 | +0.38 |
Calmar ratioReturn relative to maximum drawdown | 6.54 | 0.42 | +6.12 |
Martin ratioReturn relative to average drawdown | 25.10 | 1.02 | +24.08 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| BBC | LLY | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 3.52 | 0.29 | +3.23 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.09 | 1.23 | -1.32 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.22 | 1.04 | -0.82 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.12 | 0.56 | -0.45 |
Correlation
The correlation between BBC and LLY is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
BBC vs. LLY - Dividend Comparison
BBC's dividend yield for the trailing twelve months is around 1.57%, more than LLY's 0.68% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 1.57% | 1.70% | 1.00% | 0.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.09% | 0.00% | 0.51% |
LLY Eli Lilly and Company | 0.68% | 0.56% | 0.67% | 0.78% | 1.07% | 1.23% | 1.75% | 1.96% | 1.94% | 2.46% | 2.77% | 2.37% |
Drawdowns
BBC vs. LLY - Drawdown Comparison
The maximum BBC drawdown since its inception was -76.85%, which is greater than LLY's maximum drawdown of -68.24%. Use the drawdown chart below to compare losses from any high point for BBC and LLY.
Loading graphics...
Drawdown Indicators
| BBC | LLY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.85% | -68.24% | -8.61% |
Max Drawdown (1Y)Largest decline over 1 year | -18.03% | -30.26% | +12.23% |
Max Drawdown (5Y)Largest decline over 5 years | -72.58% | -34.48% | -38.10% |
Max Drawdown (10Y)Largest decline over 10 years | -76.85% | -34.48% | -42.37% |
Current DrawdownCurrent decline from peak | -30.71% | -17.00% | -13.71% |
Average DrawdownAverage peak-to-trough decline | -37.30% | -19.25% | -18.05% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.05% | 12.39% | -7.34% |
Volatility
BBC vs. LLY - Volatility Comparison
Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a higher volatility of 13.21% compared to Eli Lilly and Company (LLY) at 9.04%. This indicates that BBC's price experiences larger fluctuations and is considered to be riskier than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| BBC | LLY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.21% | 9.04% | +4.17% |
Volatility (6M)Calculated over the trailing 6-month period | 26.93% | 26.21% | +0.72% |
Volatility (1Y)Calculated over the trailing 1-year period | 40.92% | 42.44% | -1.52% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 39.30% | 32.14% | +7.16% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 37.86% | 29.80% | +8.06% |